Melanoma is a serious form of skin cancer that originates in the melanocytes Learn how lifestyle changes can lower the risk ...

A grandmother has turned to the public to try to help her raise tens of thousands of pounds to fund her cancer treatment ...

Replimune Group, Inc. (NASDAQ: NASDAQ:REPL), a biotechnology firm engaged in developing oncolytic immunotherapies, has applied for FDA approval for its advanced melanoma treatment, RP1 ...

Cancer cells can be very deceptive as they develop in our bodies, often not revealing their existence immediately. Sometimes, ...

Discover how elevated troponin levels signal cardiac risks in cancer patients on immunotherapy. Learn how biomarkers improve ...

Regular monitoring enables early intervention, helping prevent serious complications through timely treatment ... Regular ...

The number of Canadians diagnosed with melanoma each year has more than tripled in the past three decades. An estimated ...

REPL’s RP1 BLA Submission Supported by Robust Study Data Replimune’s BLA submission for RPI, in combination with Bristol Myers’ Opdivo, for the advanced melanoma indication ... and review of drugs for ...

A new study has revealed an unexpected potential benefit of severe Covid infection – it may help shrink cancer.

A fascinating new study, published in the Journal of Clinical Investigation, has revealed an unexpected potential benefit of ...

Few would have thought that the COVID pandemic would have a silver lining, but scientists in Chicago may just have found one.